IL169343A0 - Compounds for oral dosage of active substances requiring a taste masking - Google Patents

Compounds for oral dosage of active substances requiring a taste masking

Info

Publication number
IL169343A0
IL169343A0 IL169343A IL16934305A IL169343A0 IL 169343 A0 IL169343 A0 IL 169343A0 IL 169343 A IL169343 A IL 169343A IL 16934305 A IL16934305 A IL 16934305A IL 169343 A0 IL169343 A0 IL 169343A0
Authority
IL
Israel
Prior art keywords
compounds
active substances
oral dosage
taste masking
substances requiring
Prior art date
Application number
IL169343A
Other versions
IL169343A (en
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of IL169343A0 publication Critical patent/IL169343A0/en
Publication of IL169343A publication Critical patent/IL169343A/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/02—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops
    • B01J2/04—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops in a gaseous medium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL169343A 2002-12-23 2005-06-22 Compositions for oral administration of active ingredients with unacceptable taste and a method for masking the taste of such compositions IL169343A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0216521A FR2848855B1 (en) 2002-12-23 2002-12-23 COMPOSITIONS FOR ORAL ADMINISTRATION OF ACTIVE INGREDIENTS REQUIRING TASTE MASKING
PCT/FR2003/003813 WO2004058137A2 (en) 2002-12-23 2003-12-19 Compounds for oral dosage of active substances requiring a taste masking

Publications (2)

Publication Number Publication Date
IL169343A0 true IL169343A0 (en) 2007-07-04
IL169343A IL169343A (en) 2011-06-30

Family

ID=32406402

Family Applications (1)

Application Number Title Priority Date Filing Date
IL169343A IL169343A (en) 2002-12-23 2005-06-22 Compositions for oral administration of active ingredients with unacceptable taste and a method for masking the taste of such compositions

Country Status (14)

Country Link
EP (1) EP1587500B1 (en)
JP (1) JP4676763B2 (en)
AU (1) AU2003299360B2 (en)
BR (1) BR0317654A (en)
CA (1) CA2510373C (en)
CY (1) CY1115401T1 (en)
DK (1) DK1587500T3 (en)
ES (1) ES2470371T3 (en)
FR (1) FR2848855B1 (en)
IL (1) IL169343A (en)
MX (1) MXPA05005640A (en)
PT (1) PT1587500E (en)
SI (1) SI1587500T1 (en)
WO (1) WO2004058137A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1034065C2 (en) 2007-06-29 2008-12-30 Friesland Brands Bv Preparation of particles.
FR2959130A1 (en) 2010-04-21 2011-10-28 Sanofi Aventis PROCESS FOR PREPARING PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION COMPRISING ONE OR MORE ACTIVE INGREDIENTS AND COMPOSITIONS COMPRISING SAME
FR2968992B1 (en) 2010-12-16 2013-02-08 Sanofi Aventis ORODISPERSIBLE PHARMACEUTICAL TABLET BASED ON ZOLPIDEM
FR2968995B1 (en) 2010-12-16 2013-03-22 Sanofi Aventis PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION TO PREVENT MEASUREMENT
FR3000400B1 (en) 2012-12-27 2019-06-21 Virbac OIL SUSPENSION OF METRONIDAZOLE
EP3076947B1 (en) * 2013-12-04 2018-06-13 Hovione Scientia Limited Contrast media containing taste masking formulations
FR3027802B1 (en) * 2014-10-31 2018-03-02 Ethypharm DOUBLE MASKING TASTE ACTIVE PRINCIPLE GRANULES, PROCESS FOR THEIR PREPARATION AND ORODISPERSIBLE TABLETS CONTAINING SAME

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59122425A (en) * 1982-12-27 1984-07-14 Kaken Pharmaceut Co Ltd Sustained release preparation and its preparation
NL193682C (en) * 1987-05-14 2000-07-04 Glaxo Group Ltd Coated Cefuroxime Maxetil Composition.
FR2657257B1 (en) * 1990-01-19 1994-09-02 Rhone Poulenc Sante PROCESS FOR THE PREPARATION OF DRUGS IN THE FORM OF PEARLS.
JP3155028B2 (en) * 1991-06-10 2001-04-09 大川原化工機株式会社 Spray drying granulator
JPH05309314A (en) * 1992-05-07 1993-11-22 Sumitomo Pharmaceut Co Ltd Coating method
ES2107685T3 (en) * 1992-10-16 1997-12-01 Glaxo Group Ltd RANITIDINE COMPOSITIONS THAT MASK YOUR TASTE.
NZ505123A (en) * 1997-12-19 2003-07-25 Smithkline Beecham Corp Process for manufacturing bite-dispersion tablets by compressing medicaments and other ingredients into granulates then compressing the granulates and other ingredients into tablets, and the tablets thereof
JP2000103730A (en) * 1998-07-31 2000-04-11 Otsuka Pharmaceut Co Ltd Medicine composition having improved feeling of administration
US6209479B1 (en) * 1998-12-30 2001-04-03 Aeromatic-Fielder Ag Apparatus for coating tablets
CN1343128B (en) * 1999-03-17 2010-04-21 第一制药株式会社 Medicinal compositions

Also Published As

Publication number Publication date
CA2510373A1 (en) 2004-07-15
BR0317654A (en) 2005-12-20
CY1115401T1 (en) 2017-01-04
MXPA05005640A (en) 2005-07-27
FR2848855A1 (en) 2004-06-25
ES2470371T3 (en) 2014-06-23
WO2004058137A3 (en) 2005-04-14
DK1587500T3 (en) 2014-06-23
IL169343A (en) 2011-06-30
PT1587500E (en) 2014-06-24
SI1587500T1 (en) 2014-07-31
EP1587500A2 (en) 2005-10-26
WO2004058137A2 (en) 2004-07-15
AU2003299360B2 (en) 2009-10-29
JP2006515592A (en) 2006-06-01
AU2003299360A1 (en) 2004-07-22
CA2510373C (en) 2014-09-30
JP4676763B2 (en) 2011-04-27
EP1587500B1 (en) 2014-03-12
FR2848855B1 (en) 2005-02-11

Similar Documents

Publication Publication Date Title
IL162843A0 (en) Dosage form for oral administration of a pde4 inhibitor
PL356358A1 (en) Solid dosage form of someticone for oral administration
PL368636A1 (en) Pharmaceutical dosage forms of epothilones for oral administration
HK1070285A1 (en) Pharmaceutical dosage form of amorphous nelfinavirmesylate
PT1362582E (en) Enrobed solid dosage form
HK1064035A1 (en) Pharmaceutical salts of 1-phenyl-3-dimethylamino-propane compounds
PL360967A1 (en) Pharmaceutical compound containing donepezyl hydrochloride
HK1107768A1 (en) Solid drug for oral use
EP1372392A4 (en) Nicotine-containing oral dosage form
IL169343A0 (en) Compounds for oral dosage of active substances requiring a taste masking
PL375558A1 (en) A method of extending the dose range of vitamin d compounds
PL372773A1 (en) Oral administration of epothilones
IL166337A0 (en) Oral administration of calctionin
AU2003221699A8 (en) Pharmaceutical preparation for taste masking
EP1589950A4 (en) Methods for making pharmaceutical dosage forms containing active cushioning components
AU2003276572A1 (en) Pharmaceutical dosage forms of biguanide-sulfonylurea combinations
IL161143A0 (en) A flash-melt pharmaceutical oral dosage composition
AU2003249105A1 (en) Processes for the preparation of oral dosage formulations of modafinil
HK1072194A1 (en) Oral dosage form for controlled drug release
AU2003232652A1 (en) Oral controlled-release dosage forms containing acetaminophen
AU2003225285A1 (en) Oral dosage forms comprising fenofibrate
ZA200705012B (en) Oral solid dosage forms containing a low dose of estradiol
AU2003257102A8 (en) Pharmaceutical dosage form comprising a sulfite compound
EP1480632A4 (en) A novel dosage form of l-methionine s-sulfoximine
EP1361866A4 (en) Emulsions as solid dosage forms for oral administration

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees